freehire
/
Clene
Developing nanotechnology-based drugs for neurodegenerative diseases.
Subscribe to updates
Discussion
Biotechnology
Pharmaceuticals
clene.com ↗
Company facts
Founded
2013
Employees
80
Headquarters
United States
Type
Public
Listed
NASDAQ: CLNN
Subsidiaries
Clene Nanomedicine, Inc.